Đang chuẩn bị liên kết để tải về tài liệu:
báo cáo khoa học: " HIV/AIDS, chronic diseases and globalisation"

Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: HIV/AIDS, chronic diseases and globalisation | Colvin Globalization and Health 2011 7 31 http www.globalizationandhealth.eom content 7 1 31 H2 globalization 7 AND HEALTH DEBATE Open Access HIV AIDS chronic diseases and globalisation Christopher J Colvin Abstract HIV AIDS has always been one of the most thoroughly global of diseases. In the era of widely available antiretroviral therapy ART it is also commonly recognised as a chronic disease that can be successfully managed on a long-term basis. This article examines the chronic character of the HIV AIDS pandemic and highlights some of the changes we might expect to see at the global level as HIV is increasingly normalised as just another chronic disease . The article also addresses the use of this language of chronicity to interpret the HIV AIDS pandemic and calls into question some of the consequences of an uncritical acceptance of concepts of chronicity. Background HIV AIDS has always been one of the most thoroughly global of diseases. From its still hazily understood emergence as a zoonotic infection in colonial and post-colonial West and Central Africa and the early moral panics over a globe-trotting Patient Zero to the current situation of global pandemic it has always been intimately bound up in globalised structures and processes 1-3 . If HIV was global from its beginnings it came to be seen as chronic only shortly thereafter. In 1989 soon after the development of the first anti-retroviral monotherapies to treat AIDS Samuel Broder head of the US National Cancer Institute famously asserted at an international AIDS conference that HIV should be considered to be a chronic illness and its treatment should follow the model of cancer . The 1992 book AIDS The Making of a Chronic Disease 4 provided an historical account of HIV activism clinical treatment and pharmaceutical research in the 80s that transformed the disease from an acute and consistently fatal condition to one that promised to be manageable over the long term through drug therapy. From this initial